131 results
Page 2 of 7
8-K
EX-10.1
8q3k66 mkmb8vtty02
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
oc0btj44
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
za3co9r7a20nxlqqg
2 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
DEFA14A
5486ejddl58l4kj3d
20 Apr 22
Additional proxy soliciting materials
4:09pm
8-K
EX-1.1
76hm5mk95
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
424B5
s99krvcbiv 6bmnmyqo
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
v16su bhd3
23 Mar 22
Prospectus supplement for primary offering
5:14pm
S-8
jk6oj9us lc
28 Feb 22
Registration of securities for employees
5:06pm
S-8
EX-23.2
scx5esra27kju1klrn0r
28 Feb 22
Registration of securities for employees
5:06pm
8-K
EX-1.1
g1j4wrnxpk
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
424B5
2ch5m
20 Jan 22
Prospectus supplement for primary offering
4:45pm
8-K
xhmz 71ttd5i
10 Jan 22
Results of Operations and Financial Condition
8:00am
8-K
EX-1.1
qlyxll
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am
424B5
wz6d853 wpl
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
2m4 l0cvaatwbkfg2lfx
15 Nov 21
Prospectus supplement for primary offering
5:24pm